This compound is a protected derivative of D-threonine, featuring a fluorenylmethoxycarbonyl (Fmoc) group and a tert-butyl ether protecting group. It is commonly used as a building block in solid-phase peptide synthesis, enabling the incorporation of D-threonine residues with protected side chains.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 138797-71-4
(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxybutanoic acid
pharmaceutical intermediate
Fmoc-D-leucine
pharmaceutical intermediate
Fmoc-O-tert-butyl-D-serine
pharmaceutical intermediate
(2R,3R)-3-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-2-hydroxy-4-phenylbutanoic acid
pharmaceutical intermediate
N-Fmoc-S-(4-methoxybenzyl)-L-cysteine
pharmaceutical intermediate
2-cyclopropyl-2-oxoacetic acid
pharmaceutical intermediate
O,N-didesmethyltramadol
pharmaceutical intermediate
(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid
pharmaceutical intermediate
(2R,3S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[(2-methylpropan-2-yl)oxy]butanoic acid
LZOLWEQBVPVDPR-VBKZILBWSA-N
C[C@@H]([C@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)OC(C)(C)C